The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - ose pharma
Baseline-derived neutrophil-to-lymphocyte ratio (dNLR) and lactate dehydrogenase (LDH) to predict the benefit of immune checkpoint inhibitors (ICI) in advanced non-small cell lung cancer (NSCLC) patients.
 
Laura Mezquita
Consulting or Advisory Role - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Edouard Auclin
No Relationships to Disclose
 
Roberto Ferrara
No Relationships to Disclose
 
Clarisse Audigier-Valette
Consulting or Advisory Role - Amgen; AstraZeneca; AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Lilly; MSD; Novartis; Pfizer; Roche; Sysmex
Research Funding - AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb; Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer (Inst); Roche; Roche (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Roche
 
Laurent Tessonnier
No Relationships to Disclose
 
Melinda Charrier
No Relationships to Disclose
 
Marie Eve Boucher
No Relationships to Disclose
 
Jihene Lahmar
No Relationships to Disclose
 
Caroline Caramella
No Relationships to Disclose
 
Jordi Remon
No Relationships to Disclose
 
David Planchard
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Roche; Sanofi
 
Julien Adam
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; HalioDx; Merck Sharp & Dohme; Pfizer; Roche
Research Funding - Pierre Fabre (Inst); Sanofi (Inst)
 
Anas Gazzah
No Relationships to Disclose
 
Nathalie Chaput
Consulting or Advisory Role - Bristol-Myers Squibb; Sanofi
 
Jean-Charles Soria
Honoraria - AstraZeneca; MSD; PharmaMar; Pierre Fabre; Roche; Sanofi; SERVIER; Symphony Evolution
 
Benjamin Besse
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Inivata (Inst); Lilly (Inst); Novartis (Inst); Onxeo (Inst); ose pharma (Inst); Pfizer (Inst); Roche/Genentech (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Medarex; Novartis; Pfizer; Pierre Fabre; Roche